MRS. RAYE LYNN ABSHER FNP-C NPI 1316552664

NPI Details

MRS. Raye Lynn Absher, FNP-C is a pain medicine pain medicine in North Wilkesboro, NC with 5 years of experience. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. MRS. Raye Lynn Absher, FNP-C NPI is 1316552664. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

190 INDEPENDENCE AVE STE B
NORTH WILKESBORO, NC
ZIP 28659-270
Phone: (336) 289-2289

The NPI 1316552664 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Magnesium level (HCPCS:83735)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Vitamin d-3 level (HCPCS:82306)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Test to measure rate of airflow (HCPCS:94375)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Hemoglobin a1c level (HCPCS:83036)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Uric acid level, blood (HCPCS:84550)
• Rheumatoid factor level (HCPCS:86431)
• Urinalysis, manual test (HCPCS:81002)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• X-ray of chest, 2 views (HCPCS:71046)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)

The enumeration date for this NPI number is 9/14/2020 and was last updated on 12/7/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: